Coatings specialist joins Bayer MaterialScience

Steven Sternberger takes industrial marketing manager role

Bayer MaterialScience has appointed Steven Sternberger as industrial marketing manager for coatings in the Coatings, Adhesives and Specialties (CAS) business unit.

In this role, Sternberger will lead the CAS team’s efforts to meet evolving coatings requirements for industrial customers.

Prior to joining Bayer, Sternberger was the director of marketing for industrial coatings at PPG Industries. He has 30 years’ marketing and sales experience in many segments of the coatings industry.

You may also like

Manufacturing

Shift log management solution enhances shop floor efficiency at Bayer

Bayer AG's drug substance finishing plant in Charlottenburg, Germany, has adopted eschbach's Shiftconnector platform to streamline shop floor communication, eliminate inefficiencies and enhance operational excellence with real-time visibility and integrated workflows
Research & Development

LIfT BioSciences licenses Bayer's Cambridge lab facilities to advance oncology research

LIfT will use Bayer's Co.Lab facilities to advance its immuno-modulatory alpha neutrophil platform for the mitigation of treatment resistance in solid tumours
Regulatory

Bayer's acoramidis recommended for approval by the EMA's CHMP for cardiomyopathy

The orally administered transthyretin (TTR) stabiliser is suitable for patients with transthyretin amyloid cardiomyopathy, demonstrating at least a 90% TTR stabilisation capacity and a reduction in cardiovascular-related hospitalisations
Distribution

PanTera signs agreement with Bayer for the supply of actinium-225

The company will provide 225Ac for clinical trial needs
Research & Development

Recursion adds new chemical entity targeting fibrotic diseases to late discovery pipeline

Potential first-in-class molecule with novel target inlicensed from collaboration with Bayer
Packaging

Bayer joins the Blister Pack Collective to reduce single-use plastics in tablet packs

PA Consulting (PA), the company bringing ingenuity to life, and PulPac, the Swedish R&D and IP company behind Dry Molded Fiber, are pleased to announce the Consumer Health division of Bayer has joined the Blister Pack Collective
Ingredients

Therapeutic: asundexian for atrial fibrillation

In atrial fibrillation, the atria of the heart contract irregularly; as a result, they do not empty completely and prevent the correct flow of blood
Subscribe now